Survival outcomes in patients with early stage, resected pancreatic cancer - A comparison of gemcitabine- and 5-fluorouracil-based chemotherapy and chemoradiation regimens

International Journal of Clinical Practice

Volumn 68, Issue 5, 2014, Pages 578-589

  Kizilbash, S H ^a   Ward, K C ^b   Liang, J J ^c   Jaiyesimi, I ^a   Lipscomb, J ^b  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b EMORY UNIVERSITY   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; GEMCITABINE; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CHEMORADIOTHERAPY; EARLY CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREAS CANCER; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; VERY ELDERLY; ADJUVANT CHEMORADIOTHERAPY; ANALOGS AND DERIVATIVES; COMPARATIVE STUDY; MORTALITY; PANCREATIC NEOPLASMS; PROCEDURES; RETROSPECTIVE STUDY; SURVIVAL ANALYSIS;

AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMORADIOTHERAPY, ADJUVANT; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; HUMANS; MALE; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84899419316     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/ijcp.12353     Document Type: Article

References (20)

1. Neoptolemos JP, Stocken DD, Tudur Smith C, et al. Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials. Br J Cancer 2009; 100 (2): 246-50.
2. Oettle H, Post S, Neuhaus P, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 2007; 297 (3): 267-77.
3. Neoptolemos JP, Stocken DD, Bassi C, et al. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA 2010; 304 (10): 1073-81.
4. Kalser MH, Ellenberg SS,. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985; 120 (8): 899-903.
5. Klinkenbijl JH, Jeekel J, Sahmoud T, et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 1999; 230 (6): 776-82; discussion 782-4.
6. Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004; 350 (12): 1200-10.
7. Tempero MA, Berlin J, Ducreux M, et al. Pancreatic cancer treatment and research: an international expert panel discussion. Ann Oncol 2011; 22 (7): 1500-6.
8. National Cancer Institute. Overview of the SEER Program. http://seer.cancer.gov/about/overview.html (accessed 3 November 2013).
9. National Cancer Institute. SEER-Medicare Linked Database. http://appliedresearch.cancer.gov/seermedicare/ (accessed 3 November 2013).
10. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40 (5): 373-83.
11. Deyo RA, Cherkin DC, Ciol MA,. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45 (6): 613-9.
12. Edge SB, Byrd DR, Compton CC, et al., eds AJCC Cancer Staging Manual. 7th edn. New York, NY: Springer, 2010.
13. Klabunde CN, Potosky AL, Legler JM, Warren JL,. Development of a comorbidity index using physician claims data. J Clin Epidemiol 2000; 53 (12): 1258-67.
14. U.S. Census Bureau. Poverty. http://census.gov/hhes/www/poverty/methods/ definitions.html (accessed 3 November 2013).
15. National Cancer Institute,. SEER Cause-specific Death Classification. http://seer.cancer.gov/causespecific/ (accessed 3 November 2013).
16. Van Laethem JL, Hammel P, Mornex F, et al. Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study. J Clin Oncol 2010; 28 (29): 4450-6.
17. Regine WF, Winter KA, Abrams RA, et al. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. JAMA 2008; 299 (9): 1019-26.
18. Regine WF, Winter KA, Abrams R, et al. Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial. Ann Surg Oncol 2011; 18 (5): 1319-26.
19. National Cancer Institute. Gemcitabine Hydrochloride with or without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen with or without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients with Pancreatic Cancer that has been Removed by Surgery. http://clinicaltrials. gov/show/NCT01013649 (accessed 3 November 2013).
20. National Cancer Institute. SEER Cancer Statistics Review. http://seer.cancer.gov/csr/1975-2008/index.html (accessed 3 November 2013).